Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orr, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orr, R. K.

Annals of Surgical Oncology, Vol 6, Issue 1 109-116, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis

R. K. Orr
Division of Surgical Oncology, The Marshfield Clinic, Wisconsin 54449, USA.

BACKGROUND: Because of the general acceptance of the NSABP B-04 study, prophylactic axillary node dissection for women with clinically negative axillae is considered diagnostic, but not therapeutic, by many oncologists. Nevertheless, several authors have shown that B-04 did not include enough patients to exclude a small survival advantage. METHODS: A Bayesian meta-analysis of the available literature was performed comparing standard treatment to standard treatment without axillary node dissection. Six randomized controlled trials were identified, consisting of nearly 3000 patients and spanning four decades. RESULTS: All six trials showed that prophylactic axillary node dissection improved survival, ranging from 4% to 16%, corresponding to a risk reduction of 7%-46%. Combining the six trials showed an average survival benefit of 5.4% (95% CI = 2.7-8.0%, probability of survival benefit > 99.5%). Adjusting for biases in the individual studies did not alter the conclusions, nor did subset analysis of Stage I patients. CONCLUSIONS: Axillary node dissection improves survival in women with operable breast cancer. Nevertheless, two important limitations of this analysis are noteworthy. Few of the patients in the six trials had T1a tumors, so extrapolation of these results to this subset (and those with nonpalpable tumors) may be inappropriate. Essentially no patients in the six trials were treated with adjuvant therapy, as contrasted to current clinical practice. It is possible that the risk reduction seen in this meta-analysis may be diminished in patients receiving adjuvant chemotherapy. Despite these limitations, this study suggests that axillary dissection should be performed in most women with palpable tumors for diagnostic, as well as therapeutic, purposes.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
P. V. Pandharipande, M. G. Harisinghani, E. M. Ozanne, M. C. Specht, C. Hur, J. M. Lee, and G. S. Gazelle
Staging MR Lymphangiography of the Axilla for Early Breast Cancer: Cost-Effectiveness Analysis
Am. J. Roentgenol., November 1, 2008; 191(5): 1308 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. Poirier, L. Sideris, P. Dube, P. Drolet, and S. H. Meterissian
Analysis of Clinical Applicability of the Breast Cancer Nomogram for Positive Sentinel Lymph Node: The Canadian Experience
Ann. Surg. Oncol., September 1, 2008; 15(9): 2562 - 2567.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Olson Jr, L. M. McCall, P. Beitsch, P. W. Whitworth, D. S. Reintgen, P. W. Blumencranz, A. M. Leitch, S. Saha, K. K. Hunt, and A. E. Giuliano
Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011
J. Clin. Oncol., July 20, 2008; 26(21): 3530 - 3535.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Samphao, J. M. Eremin, M. El-Sheemy, and O. Eremin
Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach
Ann. Surg. Oncol., May 1, 2008; 15(5): 1282 - 1296.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. Reimer, R. Fietkau, S. Markmann, A. Stachs, and B. Gerber
How Important is the Axillary Nodal Status for Adjuvant Treatment Decisions at a Breast Cancer Multidisciplinary Tumor Board? A Survival Analysis
Ann. Surg. Oncol., February 1, 2008; 15(2): 472 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
D. E. Konkin, S. Tyldesley, H. Kennecke, C. H. Speers, I. A. Olivotto, and N. Davis
Management and Outcomes of Isolated Axillary Node Recurrence in Breast Cancer
Arch Surg, September 1, 2006; 141(9): 867 - 874.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. Alvarez, E. Anorbe, P. Alcorta, F. Lopez, I. Alonso, and J. Cortes
Role of Sonography in the Diagnosis of Axillary Lymph Node Metastases in Breast Cancer: A Systematic Review.
Am. J. Roentgenol., May 1, 2006; 186(5): 1342 - 1348.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. Schaapveld, E. G. E. de Vries, W. T. A. van der Graaf, R. Otter, J. de Vries, and P. H. B. Willemse
The Prognostic Effect of the Number of Histologically Examined Axillary Lymph Nodes in Breast Cancer: Stage Migration or Age Association?
Ann. Surg. Oncol., April 1, 2006; 13(4): 465 - 474.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. C. Henderson
Axillary Surgery: Clinical Judgment Required
J. Clin. Oncol., January 20, 2006; 24(3): 325 - 326.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. L. Smidt, D. M. Kuster, G. J. van der Wilt, F. B. Thunnissen, K. J. Van Zee, and L. J. A. Strobbe
Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands?
Ann. Surg. Oncol., December 1, 2005; 12(12): 1066 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. E. Davidson, M. Morrow, D. B. Kopans, and F. C. Koerner
Case 35-2005 -- A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node
N. Engl. J. Med., November 17, 2005; 353(20): 2177 - 2185.
[Full Text] [PDF]

Home page
 Ann OncolHome page
U. Veronesi, R. Orecchia, S. Zurrida, V. Galimberti, A. Luini, P. Veronesi, G. Gatti, G. D'Aiuto, L. Cataliotti, R. Paolucci, et al.
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy
Ann. Onc., March 1, 2005; 16(3): 383 - 388.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. A. Olivotto, P. T. Truong, and B. Chua
Postmastectomy Radiation Therapy: Who Needs It?
J. Clin. Oncol., November 1, 2004; 22(21): 4237 - 4239.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. N. Krag, T. B. Julian, S. P. Harlow, D. L. Weaver, T. Ashikaga, J. Bryant, R. M. Single, and N. Wolmark
NSABP-32: Phase III, Randomized Trial Comparing Axillary Resection with Sentinal Lymph Node Dissection: A Description of the Trial
Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 208S - 210S.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. M. McMasters
The Eternally Enigmatic Axilla: Further Controversy About Axillary Lymph Nodes in Breast Cancer
Ann. Surg. Oncol., December 1, 2003; 10(10): 1128 - 1130.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. J. Van Zee, D.-M. E. Manasseh, J. L. B. Bevilacqua, S. K. Boolbol, J. V. Fey, L. K. Tan, P. I. Borgen, H. S. Cody III, and M. W. Kattan
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
Ann. Surg. Oncol., December 1, 2003; 10(10): 1140 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. N. Krag and R. M. Single
Breast Cancer Survival According to Number of Nodes Removed
Ann. Surg. Oncol., December 1, 2003; 10(10): 1152 - 1159.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. A. Badwe, M. A. Thorat, V. V. Parmar, G. L. De Salvo, P. Del Bianco, G. Zavagno, A. M. Munster, K. M. McMasters, U. Veronesi, P. Maisonneuve, et al.
Sentinel-Node Biopsy in Breast Cancer
N. Engl. J. Med., November 13, 2003; 349(20): 1968 - 1971.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. N. Krag and T. B. Julian
Practice Patterns of Sentinel Node Biopsy at Five Comprehensive Cancer Centers
J Natl Cancer Inst, October 15, 2003; 95(20): 1498 - 1499.
[Full Text] [PDF]

Home page
 NEJMHome page
D. Krag and T. Ashikaga
The Design of Trials Comparing Sentinel-Node Surgery and Axillary Resection
N. Engl. J. Med., August 7, 2003; 349(6): 603 - 605.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. M. Copeland III
Breast Cancer: Specialists Do Make a Difference
Ann. Surg. Oncol., July 1, 2003; 10(6): 589 - 590.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
G. A. Porter, H. McMulkin, and P. J. Lovrics
Sentinel Lymph Node Biopsy in Breast Cancer: Canadian Practice Patterns
Ann. Surg. Oncol., April 1, 2003; 10(3): 255 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. S. Fant, M. D. Grant, S. M. Knox, S. A. Livingston, K. Ridl, R. C. Jones, and J. A. Kuhn
Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection
Ann. Surg. Oncol., March 1, 2003; 10(2): 126 - 130.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. A. Badwe, M. A. Thorat, R. W. Havaldar, A. L. Komorowski, W. Wysocki, G. Somlo, S. H. Levitt, B. Fisher, S. Anderson, and J. Bryant
Radical and Simple Mastectomy
N. Engl. J. Med., December 26, 2002; 347(26): 2170 - 2171.
[Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M A den Bakker, A van Weeszenberg, A Y de Kanter, F H Beverdam, C Pritchard, T. H van der Kwast, and M Menke-Pluymers
Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance
J. Clin. Pathol., December 1, 2002; 55(12): 932 - 935.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
T. A. Vandenberg and V. H. Bramwell
Caution with breast-conserving surgery
Can. Med. Assoc. J., November 12, 2002; 167(10): 1099 - 1099.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. R. McCready
Intraoperative Sentinel Node Assessment Is a Touchy Subject
Ann. Surg. Oncol., May 1, 2002; 9(4): 321 - 323.
[Full Text] [PDF]

Home page
 JCOHome page
L. Weir, C. Speers, Y. D'yachkova, and I. A. Olivotto
Prognostic Significance of the Number of Axillary Lymph Nodes Removed in Patients With Node-Negative Breast Cancer
J. Clin. Oncol., April 1, 2002; 20(7): 1793 - 1799.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
S. L. Wong, M. J. Edwards, C. Chao, T. M. Tuttle, R. D. Noyes, C. Woo, P. B. Cerrito, K. M. McMasters, and for the University of Louisville Breast Cancer Sen
Predicting the Status of the Nonsentinel Axillary Nodes: A Multicenter Study
Arch Surg, May 1, 2001; 136(5): 563 - 568.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Greco, F. Crippa, R. Agresti, E. Seregni, A. Gerali, R. Giovanazzi, A. Micheli, S. Asero, C. Ferraris, M. Gennaro, et al.
Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative Management
J Natl Cancer Inst, April 18, 2001; 93(8): 630 - 635.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
R. K. Orr, J. L. Hoehn, and N. F. Col
The Learning Curve for Sentinel Node Biopsy in Breast Cancer: Practical Considerations
Arch Surg, July 1, 1999; 134(7): 764 - 767.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.